In today's session, these stocks are experiencing unusual volume.
By Mill Chart
Last update: Apr 8, 2024
Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| CADL | 8.13% | CANDEL THERAPEUTICS INC (NASDAQ:CADL) has an unusual volume of 13.37M shares. The share price increased by 8.13%. This volume is 187.0% above the average 50 day volume. |
| ACOR | -3.7% | 145.22K shares of ACORDA THERAPEUTICS INC (NASDAQ:ACOR) exchanged hands today. This decline in share price leads to a decrease of 3.7%. This volume is 28.74% above the average 50 day volume. |
| HUBC | -14.94% | HUB CYBER SECURITY LTD (NASDAQ:HUBC) has an unusual volume of 4.33M shares. This decline in share price leads to a decrease of 14.94%. Compared to the average daily volume of the past 50 days, the current volume is 54.25% above, suggesting an unusual level of trading activity. |
| SPCB | -20.14% | Today, SUPERCOM LTD (NASDAQ:SPCB) stands out with a high volume of 7.9M shares. The share price experienced a decrease of 20.14%. This is 85.45% above the average daily volume of the last 50 days. The company is releasing earnings today. |
| CXAI | 18.59% | 13.79M shares of CXAPP INC (NASDAQ:CXAI) exchanged hands today. Shares are rising by 18.59%. The average daily volume over the past 50 days is 10.25M. Hence, the current volume is 34.49% above the average volume, indicating a deviation from the usual trading pattern. |
| VTSI | -8.14% | VIRTRA INC's (NASDAQ:VTSI) traded a high volume of 302.3K shares. The current market conditions have led to a price decrease of 8.14% for NASDAQ:VTSI. In comparison to the average daily volume of the last 50 days, the current volume is 28.82% above. This suggests a notable change in trading activity. |
| ALLR | 10.44% | Today's trading session witnessed an unusual volume of 5.03M shares for ALLARITY THERAPEUTICS INC (NASDAQ:ALLR). The price of NASDAQ:ALLR has increased by 10.44%, indicating upward momentum in the market. With an average daily volume of 299.22K over the past 50 days, today's volume is 2.0K% above the average, indicating a potential shift in market sentiment. |
| HUSA | -8.57% | So far 261.82K shares of HOUSTON AMERICAN ENERGY CORP (NYSEARCA:HUSA) have traded in today's session. NYSEARCA:HUSA is declining 8.57% today. The average daily volume over the past 50 days is 153.12K. Hence, the current volume is 70.99% above the average volume, indicating a deviation from the usual trading pattern. |
| XXII | -43.26% | 6.04M shares of 22ND CENTURY GROUP INC (NASDAQ:XXII) exchanged hands today. NASDAQ:XXII is showing a decline of 43.26% in today's trading. With an average volume of 2.55M over the past 50 days, the current volume is 137.0% above the average. This deviation signals a potential shift in market dynamics. |
| EFTR | -5.98% | The trading activity for EFFECTOR THERAPEUTICS INC (NASDAQ:EFTR) has surged with a volume of 535.47K shares today. The current market conditions have led to a price decrease of 5.98% for NASDAQ:EFTR. This volume is 38.31% above the average 50 day volume. |
Our unusual volume stocks screener will show you the full list.
EFFECTOR THERAPEUTICS INC
NASDAQ:EFTR (5/14/2024, 7:00:02 PM)
Premarket: 2 0 (0%)2
0 (0%)
EFTR News
5 days ago - InvestorPlaceEFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024EFTR stock results show that eFFECTOR Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
5 days ago - BusinessInsiderEFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips eFFECTOR Therapeutics (NASDAQ:EFTR) just reported results for the first quarter...
6 days ago - eFFECTOR Therapeutics, Inc.eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateDose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024 Raised $15.0 million in gross proceeds from...
a month ago - eFFECTOR Therapeutics, Inc.eFFECTOR Therapeutics to Participate in Upcoming Investor ConferenceSOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development...
a month ago - eFFECTOR Therapeutics, Inc.eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung CancerSOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development...
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!
2 months ago - InvestorPlaceEFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023EFTR stock results show that eFFECTOR Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderEFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips eFFECTOR Therapeutics (NASDAQ:EFTR) just reported results for the fourth quarte...
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expected in...
